|
WDR67 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78450000000363E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.166500E-04 |
| Normal-vs-Stage2 |
7.963700E-03 |
| Normal-vs-Stage3 |
8.438500E-04 |
| Normal-vs-Stage4 |
7.737000E-03 |
| Stage1-vs-Stage2 |
1.996850E-01 |
| Stage1-vs-Stage3 |
8.736300E-02 |
| Stage1-vs-Stage4 |
7.909000E-01 |
| Stage2-vs-Stage3 |
8.791600E-01 |
| Stage2-vs-Stage4 |
4.795000E-01 |
| Stage3-vs-Stage4 |
3.295400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.811100E-04 |
| Normal-vs-AfricanAmerican |
2.49689999998193E-06 |
| Normal-vs-Asian |
7.635900E-03 |
| Caucasian-vs-AfricanAmerican |
3.208400E-02 |
| Caucasian-vs-Asian |
5.353800E-01 |
| AfricanAmerican-vs-Asian |
8.887800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.183500E-04 |
| Normal-vs-Female |
2.12440000002534E-06 |
| Male-vs-Female |
2.860000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.177700E-02 |
| Normal-vs-Extreme_Weight |
7.376200E-03 |
| Normal-vs-Obese |
4.40390000000512E-05 |
| Normal-vs-Extreme_Obese |
3.206400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.482600E-01 |
| Normal_Weight-vs-Obese |
7.465700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.675600E-01 |
| Extreme_Weight-vs-Obese |
1.103430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.935800E-01 |
| Obese-vs-Extreme_Obese |
3.445400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.982110E-03 |
| Normal-vs-Age(41-60Yrs) |
5.73509999999278E-05 |
| Normal-vs-Age(61-80Yrs) |
6.177900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.909200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.474400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.602900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.001470E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.084000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.521300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.803620E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.22289999999692E-05 |
| Normal-VS-Type2 PRCC |
4.964400E-02 |
| Normal-VS-KIRP CIMP |
5.082200E-03 |
| Normal-VS-Unclassified PRCC |
1.302160E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.353600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.802000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.422400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.331550E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.800960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.244300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.013420E-01 |
| Normal-vs-N1 |
1.520770E-03 |
| Normal-vs-N2 |
2.814600E-01 |
| N0-vs-N1 |
1.375720E-02 |
| N0-vs-N2 |
7.951200E-01 |
| N1-vs-N2 |
3.496800E-01 |
|
|
